Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 5, 2015, Pages 514-521

  Sjoberg L C ^a   Gregory, J A ^a   Dahlen S E ^a   Nilsson, G P ^a   Adner, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

asthma; early allergic reaction; exacerbations; interleukin 33; serotonin

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 33; KETANSERIN; OXYGENASE; SEROTONIN; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG; IL33 PROTEIN, MOUSE;

AIRWAY RESISTANCE; ALLERGIC BRONCHOCONSTRICTION; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOCONSTRICTION; CELL ACTIVATION; CONTROLLED STUDY; LUNG MECHANICS; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SENSITIZATION; SEROTONIN RELEASE; SMOOTH MUSCLE CONTRACTION; SYNTHESIS; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; C57BL MOUSE; COMPLICATION; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MUTANT MOUSE STRAIN; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ASTHMA; BRONCHOCONSTRICTION; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY; INTERLEUKIN-33; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; SEROTONIN;

EID: 84926415984     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12590     Document Type: Article

References (32)

1. Wenzel SE,. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
2. Galli SJ, Tsai M,. IgE and mast cells in allergic disease. Nat Med 2012; 18: 693-704.
3. Holgate ST,. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011; 242: 205-219.
4. Makrinioti H, Toussaint M, Jackson DJ, Walton RP, Johnston SL,. Role of interleukin 33 in respiratory allergy and asthma. Lancet Respir Med 2014; 2: 226-237.
5. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
6. Lunderius-Andersson C, Enoksson M, Nilsson G,. Mast cells respond to cell injury through the recognition of IL-33. Front Immunol 2012; 3: 82.
7. Villarreal DO, Weiner DB,. Interleukin 33: a switch-hitting cytokine. Curr Opin Immunol 2014; 28: 102-106.
8. Prefontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009; 183: 5094-5103.
9. Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125: 752-754.
10. Bonnelykke K, Sleiman P, Nielsen K, Kreiner-Moller E, Mercader JM, Belgrave D, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 2013; 46: 51-55.
11. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363: 1211-1221.
12. Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011; 43: 887-892.
13. Swedin L, Ellis R, Kemi C, Ryrfeldt A, Inman M, Dahlen SE, et al. Comparison of aerosol and intranasal challenge in a mouse model of allergic airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 2010; 153: 249-258.
14. Wagers S, Lundblad LK, Ekman M, Irvin CG, Bates JH,. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol (1985) 2004; 96: 2019-2027.
15. De Bie JJ, Henricks PA, Cruikshank WW, Hofman G, Jonker EH, Nijkamp FP, et al. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma. Br J Pharmacol 1998; 124: 857-864.
16. Adner M, Rose AC, Zhang Y, Sward K, Benson M, Uddman R, et al. An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br J Pharmacol 2002; 137: 971-982.
17. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C,. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011; 186: 2523-2528.
18. Fitzpatrick PF,. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999; 68: 355-381.
19. Cyphert JM, Kovarova M, Allen IC, Hartney JM, Murphy DL, Wess J, et al. Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. J Immunol 2009; 182: 7430-7439.
20. Lei Y, Gregory JA, Nilsson GP, Adner M,. Insights into mast cell functions in asthma using mouse models. Pulm Pharmacol Ther 2013; 26: 532-539.
21. Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012; 67: 1118-1126.
22. Martin TR, Gerard NP, Galli SJ, Drazen JM,. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 1985 1988; 64: 2318-2323.
23. Weigand LA, Myers AC, Meeker S, Undem BJ,. Mast cell-cholinergic nerve interaction in mouse airways. J Physiol 2009; 587: 3355-3362.
24. Moffatt JD, Cocks TM, Page CP,. Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br J Pharmacol 2004; 141: 1159-1166.
25. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007; 87: 971-978.
26. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G,. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007; 179: 2051-2054.
27. Kaieda S, Shin K, Nigrovic PA, Seki K, Lee RT, Stevens RL, et al. Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1). J Biol Chem 2010; 285: 21478-21486.
28. Busse WW, Lemanske RF Jr, Gern JE,. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376: 826-834.
29. Snelgrove RJ, Gregory LG, Peiro T, Akthar S, Campbell GA, Walker SA, et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol 2014; 134: 583-592.
30. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID,. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
31. James A, Gyllfors P, Henriksson E, Dahlen SE, Adner M, Nilsson G, et al. Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi. Allergy 2012; 67: 958-961.
32. Balzar S, Fajt ML, Comhair SA, Erzurum SC, Bleecker E, Busse WW, et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am J Respir Crit Care Med 2011; 183: 299-309.